Estados financieros detallados de Protagenic Therapeutics, Inc. (PTIX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $0.84, PTIX cotiza a un P/E de 0.28 y un ROE del -7.94%. La capitalización bursátil es de $2M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $534 | $148 | $347 | $339 | $286 | 0 | $30 | $28218 | $50286 | $37715 |
| Beneficio Bruto | -$534 | -$148 | -$347 | -$339 | -$286 | 0 | -$30 | -$28218 | -$50286 | -$37715 |
| I+D | $417866 | $717452 | $881186 | $807947 | $699797 | $1.1M | $1.6M | $3.3M | $3.8M | $1.7M |
| Generales y Administrativos | $1.3M | $1.6M | $1.4M | $1.3M | $1.9M | $3.0M | $2.0M | $1.2M | $1.8M | $1.7M |
| Gastos Operativos | $1.8M | $2.4M | $2.3M | $2.1M | $2.6M | $4.1M | $3.6M | $4.5M | $5.7M | $5.8M |
| Beneficio Operativo | -$2.2M | -$2.4M | -$2.3M | -$2.1M | -$2.6M | -$4.1M | -$3.6M | -$4.5M | -$5.7M | -$5.8M |
| EBITDA | -$2.3M | -$2.4M | -$2.3M | -$2.1M | -$2.6M | -$4.1M | -$3.4M | -$4.5M | -$5.5M | -$8.0M |
| Gastos por Intereses | $7162 | $13890 | $2790 | $15886 | $246178 | $496912 | $137456 | $107682 | 0 | $296895 |
| Beneficio Antes de Impuestos | -$2.3M | -$2.3M | -$2.6M | -$1.8M | -$2.5M | -$4.5M | -$3.6M | -$5.0M | -$5.5M | -$5.2M |
| Impuestos | 0 | 0 | 0 | $15886 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$2.3M | -$2.3M | -$2.6M | -$1.8M | -$2.5M | -$4.5M | -$3.6M | -$5.0M | -$5.5M | -$5.2M |
| BPA | $-1.72 | $-0.88 | $-1.00 | $-0.69 | $-1.00 | $-1.24 | $-0.82 | $-1.15 | $-1.13 | $-3.45 |
| BPA Diluido | $-1.72 | $-0.88 | $-1.00 | $-0.69 | $-1.00 | $-1.24 | $-0.82 | $-1.15 | $-1.13 | $-3.45 |
| Acciones en Circulación (Diluidas) | $1.3M | $2.6M | $2.6M | $2.6M | $2.6M | $3.7M | $4.3M | $4.3M | $4.9M | $1.9M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $3.1M | $399687 | $362486 | $798623 | $671091 | $541171 | $215189 | $1.3M | $1.8M | $2.2M |
| Inversiones a Corto | 0 | $1.3M | $250388 | 0 | 0 | $9.8M | $7.8M | $2.8M | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $41523 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1074 |
| Activos Corrientes | $3.2M | $1.8M | $696273 | $841977 | $879247 | $11.1M | $8.0M | $4.2M | $1.9M | $2.3M |
| Inmovilizado Material | $1097 | $1022 | $611 | $296 | 0 | 0 | $1775 | $123332 | $73046 | $38836 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $2.1M |
| Activos Totales | $3.2M | $1.8M | $696884 | $842273 | $879247 | $11.1M | $8.0M | $4.3M | $2.0M | $2.1M |
| Cuentas por Pagar | $13400 | $10965 | $10048 | $163029 | $141860 | $278957 | $155486 | $113802 | $102962 | $2.0M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | $344230 | 0 | 0 | $3.2M |
| Pasivos Corrientes | $684857 | $561692 | $907767 | $1.2M | $655187 | $799535 | $1.1M | $655252 | $942759 | $6.8M |
| Deuda a Largo | 0 | 0 | 0 | $279370 | $1.4M | $318433 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $684857 | $561692 | $907767 | $1.5M | $2.0M | $1.1M | $1.1M | $655252 | $942759 | $6.8M |
| Reservas | -$8.6M | -$10.8M | -$13.4M | -$15.2M | -$17.7M | -$22.2M | -$25.8M | -$30.8M | -$36.3M | -$9.1M |
| Patrimonio Neto | $2.5M | $1.2M | -$210883 | -$634366 | -$1.1M | $9.9M | $6.9M | $3.7M | $1.0M | -$2.4M |
| Deuda Total | 0 | 0 | 0 | $279370 | $1.4M | $318433 | $344230 | 0 | 0 | $3.2M |
| Deuda Neta | -$3.1M | -$1.7M | -$612874 | -$519253 | $702705 | -$10.1M | -$7.6M | -$4.1M | -$1.8M | $943263 |
| Capital Circulante | $2.5M | $1.2M | -$211494 | -$355292 | $224060 | $10.3M | $6.9M | $3.5M | $940108 | -$4.5M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$2.3M | -$2.3M | -$2.6M | -$1.8M | -$2.5M | -$4.5M | -$3.6M | -$5.0M | -$5.5M | -$5.2M |
| Amortizaciones | $534 | $148 | $347 | $339 | $286 | $427137 | $30 | $28218 | $50286 | $255924 |
| Compensación en Acciones | $546134 | $888281 | $1.1M | $797761 | $1.7M | $1.5M | $864681 | $666828 | $923139 | $562951 |
| Cambio en Capital Circulante | -$1937 | -$16866 | $109731 | $702202 | -$361431 | -$140389 | $540132 | -$114412 | $467543 | $123402 |
| Flujo de Caja Operativo | -$1.1M | -$1.4M | -$1.1M | -$487990 | -$1.3M | -$2.8M | -$2.0M | -$3.7M | -$4.2M | -$4.1M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 | 0 | $4 | -$1805 | -$149775 | 0 | -$3 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | $46051 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$1.1M | -$1.4M | -$1.1M | -$487990 | -$1.3M | -$2.8M | -$2.0M | -$3.9M | -$4.2M | -$4.1M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Beneficio Neto (anual) | +0.7% | -13.2% | +31.5% | -45.6% | -77.5% | +21.4% | -40.6% | -10.5% | +6.7% | |
| Crecimiento BPA (anual) | +48.8% | -13.6% | +31.0% | -44.9% | -24.0% | +33.9% | -40.2% | +1.7% | -205.3% | |
| Cambio en Acciones (anual) | +93.3% | +0.0% | +0.0% | +0.8% | +42.6% | +17.2% | +0.6% | +12.8% | -60.5% | |
| Crecimiento FCF (anual) | -21.0% | +22.4% | +54.4% | -176.4% | -107.5% | +28.7% | -93.1% | -9.4% | +1.8% | |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.9% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-0.86 | $-0.54 | $-0.42 | $-0.19 | $-0.52 | $-0.76 | $-0.46 | $-0.89 | $-0.86 | $-2.14 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $1.3M | $2.6M | $2.6M | $2.6M | $2.6M | $3.7M | $4.3M | $4.3M | $4.9M | $1.9M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -794.18% |
| Rentabilidad sobre capital invertido | -419.98% |
| Rentabilidad sobre activos | 261.82% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 0.66 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -17.34 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -73.58 | -143.82 | -126.56 | -183.42 | -126.56 | -62.55 | -27.32 | -12.05 | -6.07 | -0.38 |
| P/VC | 67.80 | 266.24 | -1539.37 | -511.73 | -284.55 | 28.75 | 13.98 | 16.42 | 33.18 | -1.05 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Empresas relacionadas: ARTL · CARM · GTBP · INDP · LIPO · PBM · REVB
Explorar sector: Healthcare · Biotechnology
Más secciones de PTIX: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones